Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study)-Reference-Cited by-同舟云学术

Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study)

Published:2020-03-27 Issue:7 Volume:22 Page:1220-1225
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Boer Stefanie A.¹^ORCID,Reijrink Melanie¹^ORCID,Abdulahad Wayel H.²³,Hoekstra Elisa S.²,Slart Riemer H. J. A.⁴⁵,Heerspink Hiddo J. L.⁶^ORCID,Westra Johanna²^ORCID,Mulder Douwe J.¹

Affiliation:

1. Department of Internal Medicine, Division of Vascular MedicineUniversity of Groningen, University Medical Centre Groningen Groningen The Netherlands

2. Department of Rheumatology and Clinical ImmunologyUniversity of Groningen, University Medical Centre Groningen Groningen The Netherlands

3. Department of Pathology and Medical BiologyUniversity of Groningen, University Medical Centre Groningen Groningen The Netherlands

4. Department of Nuclear Medicine and Molecular ImagingUniversity of Groningen, University Medical Centre Groningen Groningen The Netherlands

5. Department of Biomedical Photonic Imaging (BMPI)University of Twente Enschede The Netherlands

6. Department of Clinical Pharmacy and PharmacologyUniversity of Groningen, University Medical Centre Groningen Groningen Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14024

Reference16 articles.

1. Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?

2. The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus

3. The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients

4. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

5. Endothelial precursors in vascular repair

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel cell therapy with ex vivo cultured peripheral blood mononuclear cells significantly impacts angiogenesis in the murine ischemic limb model;Regenerative Therapy;2024-06

2. Endothelial dysfunction and disease severity in COVID-19: Insights from circulating Tang cell counts as a potential biomarker;International Immunopharmacology;2024-03

3. The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells;Biomedicines;2023-11-14

4. Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications;Stem Cell Research & Therapy;2023-11-10

5. Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment;Arthritis Research & Therapy;2022-10-24